Shares of Altimmune Inc. (ALT) are rallying over 22% in pre-market today, after the company announced positive results from the preclinical studies of its intranasal COVID-19 vaccine candidate, AdCOVID.
from RTT - Before the Bell https://ift.tt/2CunNoQ
via IFTTT
No comments:
Post a Comment